Last reviewed · How we verify
Dermacid Silver (Lactic acid) — Competitive Intelligence Brief
phase 3
Topical antimicrobial/keratolytic agent
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Dermacid Silver (Lactic acid) (Dermacid Silver (Lactic acid)) — Sanofi. Lactic acid works as a topical antimicrobial and keratolytic agent that reduces bacterial colonization and promotes skin healing through acidification and exfoliation.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dermacid Silver (Lactic acid) TARGET | Dermacid Silver (Lactic acid) | Sanofi | phase 3 | Topical antimicrobial/keratolytic agent | ||
| Neutrogena Rapid Clear® | Neutrogena Rapid Clear® | GlaxoSmithKline | marketed | Topical antimicrobial/keratolytic agent | Cutibacterium acnes (bacterial cell membranes and proteins) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical antimicrobial/keratolytic agent class)
- GlaxoSmithKline · 1 drug in this class
- Sanofi · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dermacid Silver (Lactic acid) CI watch — RSS
- Dermacid Silver (Lactic acid) CI watch — Atom
- Dermacid Silver (Lactic acid) CI watch — JSON
- Dermacid Silver (Lactic acid) alone — RSS
- Whole Topical antimicrobial/keratolytic agent class — RSS
Cite this brief
Drug Landscape (2026). Dermacid Silver (Lactic acid) — Competitive Intelligence Brief. https://druglandscape.com/ci/dermacid-silver-lactic-acid. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab